|Browse All Terms|
|Beginning With||By Language|
|A B C D E F G H I J K L M N O P Q R S T U V W X Y Z :: All||
Any adverse event, which by its frequency (even though it may be individually not serious), significantly reduces the overall therapeutic benefits of the intervention, requires reporting to the Committee. Many times this reporting presents itself in the form of an amendment to the Investigational Drug Brochure and can often result in revision to the consent.
Publication Source: Committees on Human Research
Do you have a term that should be included in the glossary?
Submit a term for review